Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CRISthis companyCuris, Inc.	$0.71	-1.7×	2.38×	1.38×	-1.83×	-1296.5%	99.5%	-348.4%	-80.3%	-138.8%	-464.7%	-209.4%	0.3×	0.66×	-15.06×	0.49×	0.0%	0	-98.43	1	C-
ASBPAspire Biopharma Holdings, Inc.	$8.65	-9.67×	-37.14×	38,181.4×	-20.93×	-106.6%	-1.9%	-312016.9%	-394725.1%	383.9%	395.3%	-2.1%	-0.22×	-0.03×	-2.27×	0.17×	0.0%	5	-3.46	2	C
CTXRCitius Pharmaceuticals, Inc.	$0.53	-0.37×	0.2×	0×	-0.3×	67.7%	0.0%	0.0%	0.0%	-55.4%	-44.2%	-193.5%	0.03×	0.06×	-143.87×	0.62×	0.0%	3	-4.03	2	B-
ICUSeaStar Medical Holding Corporation	$1.96	-0.41×	4.78×	40.32×	-3.15×	62.3%	95.7%	-986.6%	-984.6%	-116.6%	-111.3%	-27.3%	0.05×	0.94×	-37.01×	3.63×	0.0%	2	-29.48	1	C-
PALIPalisade Bio, Inc.	$1.23	-7.83×	1.01×	0×	0.15×	97.2%	0.0%	0.0%	0.0%	-13.0%	-13.9%	-8.3%	0×	7.95×	-1,805.6×	28.95×	0.0%	4	21.12	2	C
PCSAProcessa Pharmaceuticals, Inc.	$1.90	-0.28×	0.68×	0×	0.13×	86.6%	0.0%	0.0%	0.0%	-243.2%	-250.8%	-301.9%	0×	0.41×	0×	2.54×	0.0%	1	-92.94	2	B-
Peer median	—	-0.41×	0.68×	0×	-0.3×	67.7%	0.0%	0.0%	0.0%	-55.4%	-44.2%	-27.3%	0×	0.41×	-37.01×	2.54×	0.0%	3	-4.03	2	—